1.
Dinner S, Witteles W, Afghahi A, Witteles R, Arai S, Lafayette R, Schrier SL, Liedtke M. Lenalidomide, melphalan and dexamethasone in a population of patients with immunoglobulin light chain amyloidosis with high rates of advanced cardiac involvement. Haematologica [Internet]. 2013Oct.3 [cited 2026Nov.22];98(10):1593-9. Available from: https://haematologica.org/article/view/6811